All members have the option of attending our various HTC-centric events which include:
Date: Thursday, November 21, 2024
Time: 2:00pm – 3:00pm ET
Title:
Health Equity
Description:
Please join Takeda for a webinar on Health Equity and how Takeda is making progress towards its goal of improving equitable access to treatment and care for all. Anthea will share Takeda’s broad strategy, how it relates to bleeding disorders, and offer opportunities for action to advance health equity goals.
Speaker:
Anthea Cherednichenko, VP US Hematology Franchise Head
Anthea leads the sales and marketing teams for Takeda’s Hematology portfolio. Anthea’s values aim to inspire positive patient outcomes through inclusive purpose-driven teams that drive innovation. Anthea previously served as the General Manager for Takeda Austria. Prior to that role, she was in Global and European leadership roles in Hematology based out of Switzerland. Originally from Australia, Anthea spent her early career years in medical device and health IT marketing roles in both Australia and Asia, before joining Baxter (later acquired by Takeda) in 2013. Anthea holds a Master of Public Health from the University of Sidney and Master of Business Administration from Victoria University.
